ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03625141
Brief Title: A Study Evaluating the Safety and Efficacy of Cobimetinib Plus Atezolizumab in BRAFV600 Wild-type Melanoma With Central Nervous System Metastases and Cobimetinib Plus Atezolizumab and Vemurafenib in BRAFV600 Mutation-positive Melanoma With Central Nervous System Metastases

First Submitted : August 2, 2018
First Submitted that Met QC Criteria : August 7, 2018
First Posted : August 10, 2018

Last Update Submitted that Met QC Criteria : August 7, 2018
Last Update Posted : August 10, 2018